ESR1 and cancer: In this regard, previous studies have linked the chromatin organization changes to an ERα-positive status in patients, suggesting that the activation of signaling through ERα may lead to an E2-mediated epigenetic repression affecting the genome organization and regulation of certain genes in cancer [20,21,22,23].